The report provides a detailed analysis essential for establishing an Isavuconazonium production plant. It encompasses all critical aspects necessary for Isavuconazonium production, including the cost of Isavuconazonium production, Isavuconazonium plant cost, Isavuconazonium production costs, and the overall Isavuconazonium production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Isavuconazonium production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Isavuconazonium is an antifungal medicine mainly used in hospital settings to treat serious fungal infections, especially invasive aspergillosis and mucormycosis. It serves as the prodrug of isavuconazole, which becomes active in the body and helps fight infections caused by organisms like Aspergillus and Mucorales.
It also finds its application as a drug for patients who need long-term antifungal therapy or cannot tolerate other treatments, due to reliable absorption and predictable action. It is often used in managing infections in people with weakened immune systems, including those undergoing chemotherapy, stem-cell transplants, or long-term corticosteroid therapy. It plays a major role in controlling life-threatening fungal growth effectively.
The primary factor driving the market for Isavuconazonium is its use as an antifungal medicine for treating invasive aspergillosis and mucormycosis, which boosts its demand in the healthcare and pharmaceutical sectors. Its demand as a medication in managing severe fungal infections in immunocompromised patients, including those undergoing chemotherapy or organ transplants, further fuels its clinical value and market expansion.
Rising awareness of severe fungal infections and improved diagnostic practices also contribute to its rising demand. Factors including the cost and consistent supply of specialised raw materials, adherence to strict regulatory and safety requirements, and compliance with environmental standards during production largely impact industrial Isavuconazonium procurement.
Improvements in production technology, supplier dependability, sustainable production practices, and efficient global logistics also play a major role in shaping its procurement trends and supporting the overall market for Isavuconazonium.
Raw Material for Isavuconazonium Production
According to the Isavuconazonium production plant project report, the major raw materials for Isavuconazonium production include Triazole-building intermediate - Phenyl-based intermediate.
Production Process of Isavuconazonium
The extensive Isavuconazonium production cost report consists of the following industrial production process:
- Production from Isavuconazole Intermediates: The production process of Isavuconazonium sulfate starts by first building the isavuconazole core through a series of bond-forming steps that join its triazole, phenyl, and side-chain fragments. Once the main structure is in place and any protecting groups are removed, the resulting basic intermediate is transferred into an organic phase and cleaned up through standard extractions. Then, the solution is treated with an ion-exchange resin in the bisulfate form, which exchanges the counterion on the protonated intermediate and converts it into the sulfate salt. After separating the water layer and removing the solvent, the solid is dried to obtain the finished isavuconazonium sulfate.
Isavuconazonium is the prodrug form of isavuconazole, and it appears as a white to slightly off-white, odourless solid. The pharmaceutical form used in practice is the sulfate salt, and its molecular formula is C35H36F2N8O9S2 with a molar mass of about 814.86 g/mol. It is freely soluble in water and aqueous buffers, while showing much lower solubility in many organic solvents. The compound decomposes on heating rather than forming a clean melt. The IUPAC name corresponding to the salt is isavuconazonium sulfate, and it is handled in dry form during compounding and formulation work. Contact with the raw material should be limited, as inhalation or ingestion may cause irritation or pharmacological effects associated with its antifungal activity. It is recommended to wear basic protective measures when working with it.